Latest Breaking News On - Sarah sammons - Page 1 : comparemela.com

5 FDA Solid Tumor Approvals from Spring 2024

Health care professionals celebrate 'milestone' FDA approval for HER2-positive solid tumors

An analysis of global online conversations among health care professionals on social media in April revealed tremendous enthusiasm about FDA approval of a treatment for adults with advanced HER2-positive solid tumors. The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu; AstraZeneca, Daiichi Sankyo) — a HER2-directed antibody-drug conjugate previously approved

Side Effects to Know About for Enhertu in HER2-Positive Solid Tumors

Before patients receive Enhertu for HER2-positive solid tumors, it’s important to know about the potential side effects.

Enhertu Marks First Therapy Approved Across HER2-Positive Solid Tumors

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

Sammons Spotlights Approaches Under Exploration for HER2+ Breast Cancer and Brain Metastases

Sarah Sammons, MD, discusses research efforts in breast cancer focused on HER2-directed therapeutic approaches with central nervous system activity.